Hollander David — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Hollander David has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $16K.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2024-11-19RVNCRevance Therapeutics, Inc.S — Open-market sale3.9K$4.17$16K

Companies — Last 90 Days

Frequently Asked Questions

Who is Hollander David?

Hollander David is a corporate insider — currently tracked as Director of KIORA PHARMACEUTICALS INC (KPRX). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Hollander David submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Hollander David been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($16K) across all tracked filings.

Where can I see all of Hollander David's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Hollander David profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.